Ricardo Ortiz
General Practice · Orocovis, PRNPI 1508004151
Payments from drug & device makers
Across 153 payments — averaging $25.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Eli Lilly Export S.A. Puerto Rico Branch$1K
- Bayer Puerto Rico Inc.$497
- Novo Nordisk$438
- Salvin Dental Specialties, Inc.$338
- AstraZeneca$239
- Boehringer Ingelheim$180
- plus $997 from 13 others
What the payments were for
- Food & beverage$3,944100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Eli Lilly Export S.A. Puerto Rico Branch | 54 | $1,260 |
| Bayer Puerto Rico Inc. | 18 | $497 |
| Novo Nordisk | 21 | $438 |
| Salvin Dental Specialties, Inc. | 2 | $338 |
| AstraZeneca | 14 | $239 |
| Boehringer Ingelheim | 6 | $180 |
| Dexcom, Inc. | 6 | $145 |
| Sanofi-aventis U.S. LLC | 1 | $143 |
| PBG Puerto Rico LLC | 6 | $123 |
| Merck | 6 | $107 |
| AbbVie | 4 | $96 |
| Amgen | 5 | $95 |
| Lilly USA, LLC | 1 | $89 |
| Bayer | 4 | $88 |
| Johnson & Johnson | 1 | $28 |
| Medicure Pharma Inc. | 1 | $25 |
| Boston Scientific | 1 | $23 |
| Radius Health, Inc. | 1 | $20 |
| Pfizer Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TZIELD$143
- TOUJEO$143
- SOLIQUA 100/33$143
How this compares
$3,950 in reported general payments places this provider in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Xigduo XrDapaglifloz Propaned/Metformin | 15 | $12,749 |
| SynthroidLevothyroxine Sodium | 35 | $4,154 |
| LantusInsulin Glargine,hum.Rec.Anlog | 29 | $2,297 |
| Omega-3 Acid Ethyl Esters | 23 | $1,899 |
| Fenofibrate | 19 | $1,110 |
| Insulin Glargine-Yfgn | 13 | $929 |
| Atorvastatin Calcium | 58 | $849 |
| Levothyroxine Sodium | 41 | $817 |
| Rosuvastatin Calcium | 27 | $664 |
| Simvastatin | 55 | $612 |
| Metoprolol Succinate | 25 | $600 |
| Pantoprazole Sodium | 51 | $581 |
| Glipizide ErGlipizide | 18 | $578 |
| Losartan Potassium | 40 | $554 |
| FenofibrateFenofibrate Nanocrystallized | 25 | $519 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieSynthroid | $96 | $4,15435 claims |
| Sanofi-aventis U.S. LLCLantus | $143 | $2,29729 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,586 general practice providers in Puerto Rico.
Other general practice in Orocovis
- Gregorio Cortes-MaisonetSan Juan$12.8M
- Barbara Orozco PerezCanovanas$5.1M
- Jesus Rodriguez RodriguezPonce$4.9M
- Luis PaganDorado$3.3M
- Cindy MartinezHormigueros$3.2M
- Gustavo AlbizuMorovis$3.1M
- Elham GhorbaniDorado$1.2M
- Victor MorenoMaunabo$903K
- Grisselle Ortiz RiveraMorovis$715K
- Elba PerezTrujillo Alto$651K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.